Sprint Bioscience AB (publ)
Sprint Bioscience AB (publ) operates in various business sectors.
Sprint Bioscience AB (publ) (5JA1) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.196x
Based on the latest financial reports, Sprint Bioscience AB (publ) (5JA1) has a cash flow conversion efficiency ratio of -0.196x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.66 Million) by net assets (€18.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sprint Bioscience AB (publ) - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how Sprint Bioscience AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sprint Bioscience AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sprint Bioscience AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grom Social Enterprises Inc
NASDAQ:GROM
|
-0.154x |
|
TERNIENERGIA
MU:TI5
|
N/A |
|
Leopard Energy, Inc.
PINK:LEEN
|
0.287x |
|
MEWAH INTL
BE:MWX
|
-0.115x |
|
Mind Gym Ltd
LSE:MIND
|
0.214x |
|
Tavistock Investments Plc
LSE:TAVI
|
-0.096x |
|
Scoobeez Global Inc
PINK:SCBZ
|
-0.062x |
|
Koza Polyester Sanayi ve Ticaret A.S.
IS:KOPOL
|
-0.001x |
Annual Cash Flow Conversion Efficiency for Sprint Bioscience AB (publ) (2018–2023)
The table below shows the annual cash flow conversion efficiency of Sprint Bioscience AB (publ) from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €27.77 Million | €22.87 Million | 0.823x | +139.36% |
| 2022-12-31 | €28.19 Million | €-58.98 Million | -2.092x | -267.45% |
| 2021-12-31 | €70.45 Million | €-40.12 Million | -0.569x | +83.84% |
| 2020-12-31 | €9.14 Million | €-32.22 Million | -3.524x | -38.64% |
| 2019-12-31 | €11.02 Million | €-28.00 Million | -2.542x | -396.07% |
| 2018-12-31 | €37.24 Million | €-19.08 Million | -0.512x | -- |